According to the National Cancer Institute (NCI), the standard treatment for multiple myeloma is a combination of:
* bortezomib (Velcade), a chemotherapy drug
* lenalidomide (Revlimid), an immunomodulator
* dexamethasone, a corticosteroid
Regarding success rates, the NCI also reports that adding the targeted therapy drug daratumumab (Darzalex) to the standard treatment of multiple myeloma was more successful than standard treatment alone.